Fingerprint
Dive into the research topics of 'Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines
Makoto Kubo, Masayo Umebayashi, Kanako Kurata, Hitomi Mori, Masaya Kai, Hideya Onishi, Mitsuo Katano, Masafumi Nakamura, Takashi Morisaki
Research output: Contribution to journal › Article › peer-review
16
Citations
(Scopus)